Corporate News

Evonik Industries AG occupies a strategic position in a fast‑growing segment of the animal‑feed market that is increasingly distancing itself from antibiotic growth promoters. The company’s probiotic portfolio—grounded in scientifically validated bacterial strains and advanced fermentation processes—aligns with global trends toward more sustainable livestock production.

Recent market analyses confirm that bacterial probiotics will retain a dominant share of the feed‑additive sector. This dominance is driven primarily by two factors:

  1. Thermal stability during pelleting – The high‑temperature process used to produce pelleted feed can compromise many additives. Probiotics engineered for heat resilience survive the pelleting step, ensuring that active microbes reach the animal gut.
  2. Efficacy in gut health and feed conversion – Studies demonstrate that probiotic inclusion improves microbial balance in the digestive tract, leading to higher feed‑to‑gain ratios and lower disease incidence.

Liquid formulations are also gaining traction. Post‑pellet application technologies preserve microbial viability and enable uniform dosing, providing flexibility for producers who manage diverse flock or herd sizes.

Evonik’s Strategic Focus

Evonik’s strategy centers on research and development in microbiome science and precision nutrition. This dual emphasis positions the company to deliver customized solutions across poultry, swine, and cattle systems. Key elements of the strategy include:

  • Collaborative integration – Partnerships with commercial feed manufacturers and livestock integrators facilitate the seamless incorporation of Evonik’s products into standard feeding regimes.
  • Technological innovation – Investment in encapsulation technologies protects probiotic viability during storage and handling, while automated application systems enhance product performance and operational efficiency.

These initiatives reinforce Evonik’s capacity to respond to the evolving needs of producers and to scale its solutions across global markets.

Regulatory and Consumer Drivers

Regulatory pressure to curtail antibiotic use, coupled with rising consumer demand for residue‑free meat, is accelerating the adoption of probiotic additives. Evonik’s proactive compliance with international feed‑additive regulations, coupled with a robust global support network, equips the company to meet these stringent standards. The firm’s commitment to regulatory excellence and its extensive scientific expertise give it a competitive advantage in markets where compliance is becoming a differentiator.

Outlook

As the animal‑feed market continues to expand, Evonik’s focus on scalability, technological innovation, and precision nutrition is likely to strengthen its competitive standing. By maintaining rigorous research standards and forging strong industry partnerships, the company is positioned to contribute substantially to the sector’s sustainable development while delivering measurable value to its customers.